Maraviroc Patents

Given below is the list of patents protecting Maraviroc, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Maraviroc's patents.

Latest Legal Activities on Maraviroc's Patents

Given below is the list recent legal activities going on the following patents of Maraviroc.

Activity	Date	Patent Number
Critical Events for all Patents
Payment of Maintenance Fee, 12th Year, Large Entity	28 Sep, 2020	US7576097
Payment of Maintenance Fee, 12th Year, Large Entity	22 Oct, 2019	US7368460
Patent Term Extension Application under 35 USC 156 Filed	16 Jun, 2010	US6667314
Notice of Final Determination -Eligible	23 Feb, 2010	US6667314
FDA Final Eligibility Letter Critical	30 Sep, 2009	US6667314
Patent Issue Date Used in PTA Calculation Critical	18 Aug, 2009	US7576097
Recordation of Patent Grant Mailed Critical	18 Aug, 2009	US7576097
Email Notification Critical	30 Jul, 2009	US7576097
Issue Notification Mailed Critical	29 Jul, 2009	US7576097
Application Is Considered Ready for Issue Critical	16 Jul, 2009	US7576097